Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2026-03-03 @ 6:47 PM
Study NCT ID:
NCT03029858
Status:
UNKNOWN
Last Update Posted:
2017-01-24
First Post:
2017-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PD-L1 and Other Immuno-markers Influenced by Osimertinib Treatment in Advanced NSCLC Patients
Sponsor:
Guangdong Association of Clinical Trials
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
None
Primary Completion Date:
2020-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-09
Completion Date Type:
ESTIMATED
First Submit Date:
2017-01-17
First Submit QC Date:
None
Study First Post Date:
2017-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-20
Last Update Post Date:
2017-01-24
Last Update Post Date Type:
ESTIMATED